share_log

Healthcare Services Group Analyst Ratings

Healthcare Services Group Analyst Ratings

醫療服務集團分析師評級
Benzinga ·  2023/10/27 00:22
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/26/2023 61.45% Benchmark $18 → $16 Maintains Buy
08/31/2023 81.63% Benchmark → $18 Reiterates Buy → Buy
08/01/2023 61.45% RBC Capital → $16 Reiterates Outperform → Outperform
07/27/2023 61.45% RBC Capital $17 → $16 Maintains Outperform
04/28/2023 71.54% Credit Suisse $14 → $17 Maintains Neutral
04/27/2023 71.54% RBC Capital → $17 Reiterates → Outperform
03/24/2023 41.27% Jefferies $8.5 → $14 Upgrades Underperform → Hold
02/21/2023 81.63% Benchmark → $18 Reiterates → Buy
02/17/2023 41.27% Credit Suisse $12 → $14 Maintains Neutral
02/17/2023 71.54% RBC Capital $14 → $17 Upgrades Sector Perform → Outperform
02/13/2023 81.63% Benchmark → $18 Reiterates → Buy
10/20/2022 81.63% Benchmark → $18 Upgrades Hold → Buy
10/20/2022 21.09% Credit Suisse $15 → $12 Maintains Neutral
10/20/2022 41.27% RBC Capital $17 → $14 Maintains Sector Perform
04/21/2022 81.63% Credit Suisse $17 → $18 Maintains Neutral
04/21/2022 101.82% RBC Capital $17 → $20 Maintains Sector Perform
02/10/2022 36.23% Jefferies $19 → $13.5 Downgrades Hold → Underperform
10/22/2021 122% Credit Suisse $28 → $22 Maintains Neutral
10/21/2021 101.82% RBC Capital $29 → $20 Maintains Sector Perform
10/20/2021 — William Blair Downgrades Outperform → Market Perform
07/22/2021 192.63% RBC Capital $30 → $29 Maintains Sector Perform
02/11/2021 212.82% Credit Suisse $32 → $31 Maintains Neutral
10/22/2020 162.36% Credit Suisse $31 → $26 Maintains Neutral
07/23/2020 192.63% Baird → $29 Downgrades Outperform → Neutral
07/07/2020 — Northland Capital Markets Downgrades Outperform → Market Perform
07/06/2020 — Benchmark Downgrades Buy → Hold
04/22/2020 172.45% Credit Suisse $32 → $27 Maintains Outperform
04/22/2020 111.91% RBC Capital $26 → $21 Maintains Sector Perform
04/20/2020 182.54% Baird → $28 Upgrades Neutral → Outperform
11/22/2019 162.36% RBC Capital → $26 Initiates Coverage On → Sector Perform
10/23/2019 243.09% Benchmark $37 → $34 Reiterates → Buy
07/24/2019 333.91% Sidoti & Co. $51 → $43 Maintains Buy
07/24/2019 253.18% Credit Suisse $41 → $35 Maintains Outperform
07/12/2019 222.91% Jefferies $40 → $32 Downgrades Buy → Hold
05/01/2019 202.72% Stifel $33 → $30 Maintains Sell
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月26日 61.45% 基準 $18→$16 維護 買
2023年08月31日 81.63% 基準 →$18 重申 購買→購買
08/01/2023 61.45% 加拿大皇家銀行資本 →$16 重申 跑贏→跑贏大盤
07/27/2023 61.45% 加拿大皇家銀行資本 $17→$16 維護 跑贏大盤
04/28/2023 71.54% 瑞士信貸 $14→$17 維護 中性
04/27/2023 71.54% 加拿大皇家銀行資本 →$17 重申 →跑贏大盤
03/24/2023 41.27% 傑富瑞 $8.5→$14 升級 表現不佳的→保持
02/21/2023 81.63% 基準 →$18 重申 →購買
02/17/2023 41.27% 瑞士信貸 $12→$14 維護 中性
02/17/2023 71.54% 加拿大皇家銀行資本 $14→$17 升級 行業表現優於→
02/13/2023 81.63% 基準 →$18 重申 →購買
10/20/2022 81.63% 基準 →$18 升級 持有→購買
10/20/2022 21.09% 瑞士信貸 $15→$12 維護 中性
10/20/2022 41.27% 加拿大皇家銀行資本 $17→$14 維護 行業表現
04/21/2022 81.63% 瑞士信貸 $17→$18 維護 中性
04/21/2022 101.82% 加拿大皇家銀行資本 $17→$20 維護 行業表現
02/10/2022 36.23% 傑富瑞 $19→$13.5 評級下調 持有→表現不佳
10/22/2021 122% 瑞士信貸 $28→$22 維護 中性
2021/10/21 101.82% 加拿大皇家銀行資本 $29→$20 維護 行業表現
10/20/2021 - 威廉·布萊爾 評級下調 跑贏→市場表現
07/22/2021 192.63% 加拿大皇家銀行資本 $30→$29 維護 行業表現
02/11/2021 212.82% 瑞士信貸 $32→$31 維護 中性
10/22/2020 162.36% 瑞士信貸 $31→$26 維護 中性
07/23/2020 192.63% 貝爾德 →$29 評級下調 跑贏→中性
07/07/2020 - 北國資本市場 評級下調 跑贏→市場表現
07/06/2020 - 基準 評級下調 購買→Hold
04/22/2020 172.45% 瑞士信貸 $32→$27 維護 跑贏大盤
04/22/2020 111.91% 加拿大皇家銀行資本 $26→$21 維護 行業表現
04/20/2020 182.54% 貝爾德 →$28 升級 中性→表現優異
2019年11月22日 162.36% 加拿大皇家銀行資本 →$26 開始承保 →行業表現
2019年10月23日 243.09% 基準 $37→$34 重申 →購買
2019年07月24日 333.91% 西多蒂公司 $51→$43 維護 買
2019年07月24日 253.18% 瑞士信貸 $41→$35 維護 跑贏大盤
2019年07月12日 222.91% 傑富瑞 $40→$32 評級下調 購買→Hold
2019年05月01日 202.72% Stifel $33→$30 維護 賣

What is the target price for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的目標價格是多少？

The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by Benchmark on October 26, 2023. The analyst firm set a price target for $16.00 expecting HCSG to rise to within 12 months (a possible 61.45% upside). 11 analyst firms have reported ratings in the last year.

基準於2023年10月26日報道了醫療服務集團(納斯達克：HCSG)的最新目標價。這家分析公司將目標價定為16.00美元，預計HCSG將在12個月內上漲至61.45%(可能上漲61.45%)。過去一年，有11家分析公司公佈了評級。

What is the most recent analyst rating for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的最新分析師評級是多少？

The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by Benchmark, and Healthcare Services Group maintained their buy rating.

醫療保健服務集團(納斯達克：HCSG)的最新分析師評級由Benchmark提供，醫療保健服務集團維持買入評級。

When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.

分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與醫療保健服務集團的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。醫療服務集團的上一次評級是在2023年10月26日提交的，所以你應該預計下一次評級將在2024年10月26日左右的某個時候公佈。

Is the Analyst Rating Healthcare Services Group (HCSG) correct?

分析師對醫療服務集團(HCSG)的評級正確嗎？

While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a maintained with a price target of $18.00 to $16.00. The current price Healthcare Services Group (HCSG) is trading at is $9.91, which is out of the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的醫療服務集團(HCSG)評級維持不變，目標價在18.00美元至16.00美元之間。醫療保健服務集團(HCSG)目前的股價為9.91美元，超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論